Open Philanthropy recommended a grant of $5,732,100 over two years to the Vaccine Formulation Institute to support the clinical development of novel, open-access adjuvants. Adjuvants are key components added to vaccines that enhance the body’s immune response — an essential step in developing effective vaccines against complex global health diseases.
This falls within Open Philanthropy’s focus area of global health R&D.